These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38178276)

  • 1. Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections.
    Wang X; Wang D; Lu H; Wang X; Wang X; Su J; Xia G
    Small; 2024 Mar; 20(10):e2305988. PubMed ID: 38178276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in nanotechnology for eradicating bacterial biofilm.
    Sahli C; Moya SE; Lomas JS; Gravier-Pelletier C; Briandet R; Hémadi M
    Theranostics; 2022; 12(5):2383-2405. PubMed ID: 35265216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control.
    Liu Y; Shi L; Su L; van der Mei HC; Jutte PC; Ren Y; Busscher HJ
    Chem Soc Rev; 2019 Jan; 48(2):428-446. PubMed ID: 30601473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent nanotechnology-based strategies for interfering with the life cycle of bacterial biofilms.
    Wu J; Zhang B; Lin N; Gao J
    Biomater Sci; 2023 Feb; 11(5):1648-1664. PubMed ID: 36723075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
    Singh A; Amod A; Pandey P; Bose P; Pingali MS; Shivalkar S; Varadwaj PK; Sahoo AK; Samanta SK
    Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35105823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Strategies to Combat Bacterial Biofilms.
    Hemmati F; Rezaee MA; Ebrahimzadeh S; Yousefi L; Nouri R; Kafil HS; Gholizadeh P
    Mol Biotechnol; 2021 Jul; 63(7):569-586. PubMed ID: 33914260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.
    Alabresm A; Chandler SL; Benicewicz BC; Decho AW
    Bioconjug Chem; 2021 Aug; 32(8):1411-1430. PubMed ID: 34319073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled drug delivery systems in eradicating bacterial biofilm-associated infections.
    Liu Y; Li Y; Shi L
    J Control Release; 2021 Jan; 329():1102-1116. PubMed ID: 33098913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
    Colilla M; Vallet-Regí M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives.
    Panthi VK; Fairfull-Smith KE; Islam N
    Int J Pharm; 2024 Apr; 655():124046. PubMed ID: 38554739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles approach to eradicate bacterial biofilm-related infections: A critical review.
    Al-Wrafy FA; Al-Gheethi AA; Ponnusamy SK; Noman EA; Fattah SA
    Chemosphere; 2022 Feb; 288(Pt 2):132603. PubMed ID: 34678351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.
    Zhang L; Bera H; Wang H; Wang J; Guo Y; Shi C; Cun D; Moser C; Høiby N; Yang M
    Int J Pharm; 2022 Mar; 616():121507. PubMed ID: 35085729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-/Nanorobots in Antimicrobial Applications: Recent Progress, Challenges, and Opportunities.
    Zhang Z; Wang L; Chan TKF; Chen Z; Ip M; Chan PKS; Sung JJY; Zhang L
    Adv Healthc Mater; 2022 Mar; 11(6):e2101991. PubMed ID: 34907671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting Quorum Sensing by Active Targeted pH-Sensitive Nanoparticles for Enhanced Antibiotic Therapy of Biofilm-Associated Bacterial Infections.
    Chen Y; Gao Y; Huang Y; Jin Q; Ji J
    ACS Nano; 2023 Jun; 17(11):10019-10032. PubMed ID: 37234036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Biofilm Formation on Biomaterials and Approaches to Its Treatment and Prevention.
    Li P; Yin R; Cheng J; Lin J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.